multidrug-resistant tuberculosis (MDR-TB)
See the following -
AHRQ Providing Support for OpenMRS
As the AHRQ report explains it, “PIH and the Regenstrief Institute in Indianapolis conceived of OpenMRS in 2005 as a flexible, open source EMR that would be capable of meeting the demand for high-quality health information in developing countries such as Rwanda and Kenya, where the two organizations were then working. Read More »
- Login to post comments
CSIR Tuberculosis Drug Project Enters Phase II Clinical Trials
The Council of Scientific and Industrial Research’s (CSIR) open source drug discovery (OSDD) project on Monday handed over a new drug combination to the Lala Ram Sarup TB Hospital in New Delhi to take it forward for so-called Phase IIB clinical trials to study the efficacy of the drug that will target multi-drug resistant tuberculosis in Indian patients.
- Login to post comments
Harnessing New Technologies To Tackle An Old Disease
Though more than 3,500 people worldwide died of tuberculosis (TB) today, you won't see it reported in headlines of any major American newspaper. Neither will you see that March 24 is World TB Day simply because for many Americans it is a disease that doesn't hit home, but this could quickly change. Read More »
- Login to post comments
Poor Uptake By Healthcare Workers In mHealth Pilot Program
A pilot study of an app for mobile healthcare workers in a rural South African multidrug-resistant tuberculosis (MDR-TB) treatment program has valuable lessons for scaling new mHealth initiatives in other resource-constrained environments, concludes an article published in PLoS Medicine. Read More »
- Login to post comments